<article xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><front><journal-meta><journal-id journal-id-type="nlm-ta">Clin Transl Gastroenterol</journal-id><journal-id journal-id-type="iso-abbrev">Clin Transl Gastroenterol</journal-id><journal-title-group><journal-title>Clinical and Translational Gastroenterology</journal-title></journal-title-group><issn pub-type="epub">2155-384X</issn><publisher><publisher-name>Nature Publishing Group</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">26986656</article-id><article-id pub-id-type="pmc">4822094</article-id><article-id pub-id-type="pii">ctg201615</article-id><article-id pub-id-type="doi">10.1038/ctg.2016.15</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Contributions</subject></subj-group></article-categories><title-group><article-title>More Is Not Always Better: A Randomized Trial Of Low Volume Oral Laxative, Enemas, And Combination Of Both Demonstrate That Enemas Alone Are Most Efficacious For Preparation For Flexible Sigmoidoscopy</article-title><alt-title alt-title-type="running">Colon Cleansing Trial for Flexible Sigmoidoscopy</alt-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Hookey</surname><given-names>Lawrence</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="caf1">*</xref></contrib><contrib contrib-type="author"><name><surname>Haimanot</surname><given-names>Samson</given-names></name><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Marchut</surname><given-names>Katherine</given-names></name><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Vanner</surname><given-names>Stephen</given-names></name><xref ref-type="aff" rid="aff1">1</xref></contrib><aff id="aff1"><label>1</label><institution>Gastrointestinal Diseases Research Unit, Department of Medicine, Queen's University</institution>, Kingston, Ontario, <country>Canada</country></aff></contrib-group><author-notes><corresp id="caf1"><label>*</label><institution>Division of Gastroenterology, Hotel Dieu Hospital</institution>, 166 Brock Street, Kingston, Ontario K7L 5G2, <country>Canada</country>. E-mail: <email>hookeyl@hdh.kari.net</email></corresp></author-notes><pub-date pub-type="ppub"><month>03</month><year>2016</year></pub-date><pub-date pub-type="epub"><day>17</day><month>03</month><year>2016</year></pub-date><pub-date pub-type="pmc-release"><day>1</day><month>3</month><year>2016</year></pub-date><volume>7</volume><issue>3</issue><fpage>e156</fpage><lpage></lpage><history><date date-type="received"><day>15</day><month>10</month><year>2015</year></date><date date-type="rev-recd"><day>16</day><month>01</month><year>2016</year></date><date date-type="accepted"><day>21</day><month>01</month><year>2016</year></date></history><permissions><copyright-statement>Copyright © 2016 American College of Gastroenterology</copyright-statement><copyright-year>2016</copyright-year><copyright-holder>American College of Gastroenterology</copyright-holder><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc-nd/4.0/"><license-p><italic>Clinical and Translational Gastroenterology</italic> is an open-access journal published by <italic>Nature Publishing Group</italic>. This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License. The images or other third party material in this article are included in the article's Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc-nd/4.0/">http://creativecommons.org/licenses/by-nc-nd/4.0/</ext-link></license-p></license></permissions><abstract><sec><title><offsets xml_i="4100" xml_f="4111" txt_i="11" txt_f="22">Objectives:</offsets></title><p><offsets xml_i="4122" xml_f="4609" txt_i="23" txt_f="510">Colon cleansing for flexible sigmoidoscopy using a standard fleet enema does not provide adequate cleansing in a significant number of patients. We tested whether the addition of a low-volume oral cleansing agent could mitigate this challenge without significantly compromising patient tolerance. Hypothesis: Oral picosulfate with magnesium citrate (P/MC) would enhance the colon cleansing of patients undergoing sigmoidoscopy, as assessed by the modified Ottawa Bowel Preparation Score.</offsets></p></sec><sec><title><offsets xml_i="4631" xml_f="4639" txt_i="512" txt_f="520">Methods:</offsets></title><p><offsets xml_i="4650" xml_f="5084" txt_i="521" txt_f="955">A randomized single blinded trial comparing (1) a single dose (i.e., one sachet) of oral sodium picosulfate plus magnesium citrate (P/MC) administered the night before, (2) a single dose oral P/MC the night before plus sodium phosphate enema 1 h before leaving home, and (3) sodium phosphate enema alone 1 h before leaving home for flexible sigmoidoscopy was conducted on outpatients referred for sigmoidoscopy for symptom assessment.</offsets></p></sec><sec><title><offsets xml_i="5106" xml_f="5114" txt_i="957" txt_f="965">Results:</offsets></title><p><offsets xml_i="5125" xml_f="5259" txt_i="966" txt_f="1100">A total 120 patients were randomized to the study groups. The main indication for sigmoidoscopy was investigation of rectal bleeding (</offsets><italic><offsets xml_i="5267" xml_f="5268" txt_i="1100" txt_f="1101">n</offsets></italic><offsets xml_i="5277" xml_f="5506" txt_i="1101" txt_f="1330">=80). There was no significant difference in bowel cleansing quality, measured by the endoscopist blinded to preparation, between P/MC, P/MC plus enema, and enema alone as measured by the modified Ottawa Bowel Preparation Scale (</offsets><italic><offsets xml_i="5514" xml_f="5515" txt_i="1330" txt_f="1331">P</offsets></italic><offsets xml_i="5524" xml_f="5555" txt_i="1331" txt_f="1362">=0.34) or the Aronchick Scale (</offsets><italic><offsets xml_i="5563" xml_f="5564" txt_i="1362" txt_f="1363">P</offsets></italic><offsets xml_i="5573" xml_f="5720" txt_i="1363" txt_f="1510">=0.13). Both oral P/MC regimens were associated with higher incidence of nausea, abdominal pain, bloating, and interrupted sleep than enema alone (</offsets><italic><offsets xml_i="5728" xml_f="5729" txt_i="1510" txt_f="1511">P</offsets></italic><offsets xml_i="5738" xml_f="5748" txt_i="1511" txt_f="1518">&lt;0.05).</offsets></p></sec><sec><title><offsets xml_i="5770" xml_f="5782" txt_i="1520" txt_f="1532">Conclusions:</offsets></title><p><offsets xml_i="5793" xml_f="5999" txt_i="1533" txt_f="1739">A single dose of oral P/MC administered the night before did not result in better colon cleansing for sigmoidoscopy when used alone or with an enema and was associated with more side effects (NCT 01554111).</offsets></p></sec></abstract></article-meta></front><body><sec><title><offsets xml_i="6061" xml_f="6073" txt_i="1748" txt_f="1760">Introduction</offsets></title><p><offsets xml_i="6084" xml_f="6256" txt_i="1761" txt_f="1933">Flexible sigmoidoscopy maintains an important role in the diagnostic algorithm of several clinical presentations (for example, painless rectal bleeding in younger patients)</offsets><sup><xref ref-type="bibr" rid="bib1"><offsets xml_i="6294" xml_f="6295" txt_i="1933" txt_f="1934">1</offsets></xref><offsets xml_i="6302" xml_f="6304" txt_i="1934" txt_f="1936">, </offsets><xref ref-type="bibr" rid="bib2"><offsets xml_i="6337" xml_f="6338" txt_i="1936" txt_f="1937">2</offsets></xref><offsets xml_i="6345" xml_f="6347" txt_i="1937" txt_f="1939">, </offsets><xref ref-type="bibr" rid="bib3"><offsets xml_i="6380" xml_f="6381" txt_i="1939" txt_f="1940">3</offsets></xref></sup><offsets xml_i="6394" xml_f="6452" txt_i="1940" txt_f="1998"> and is a proven screening modality for colorectal cancer.</offsets><sup><xref ref-type="bibr" rid="bib3"><offsets xml_i="6490" xml_f="6491" txt_i="1998" txt_f="1999">3</offsets></xref><offsets xml_i="6498" xml_f="6500" txt_i="1999" txt_f="2001">, </offsets><xref ref-type="bibr" rid="bib4"><offsets xml_i="6533" xml_f="6534" txt_i="2001" txt_f="2002">4</offsets></xref><offsets xml_i="6541" xml_f="6543" txt_i="2002" txt_f="2004">, </offsets><xref ref-type="bibr" rid="bib5"><offsets xml_i="6576" xml_f="6577" txt_i="2004" txt_f="2005">5</offsets></xref><offsets xml_i="6584" xml_f="6586" txt_i="2005" txt_f="2007">, </offsets><xref ref-type="bibr" rid="bib6"><offsets xml_i="6619" xml_f="6620" txt_i="2007" txt_f="2008">6</offsets></xref><offsets xml_i="6627" xml_f="6629" txt_i="2008" txt_f="2010">, </offsets><xref ref-type="bibr" rid="bib7"><offsets xml_i="6662" xml_f="6663" txt_i="2010" txt_f="2011">7</offsets></xref><offsets xml_i="6670" xml_f="6672" txt_i="2011" txt_f="2013">, </offsets><xref ref-type="bibr" rid="bib8"><offsets xml_i="6705" xml_f="6706" txt_i="2013" txt_f="2014">8</offsets></xref><offsets xml_i="6713" xml_f="6715" txt_i="2014" txt_f="2016">, </offsets><xref ref-type="bibr" rid="bib9"><offsets xml_i="6748" xml_f="6749" txt_i="2016" txt_f="2017">9</offsets></xref><offsets xml_i="6756" xml_f="6758" txt_i="2017" txt_f="2019">, </offsets><xref ref-type="bibr" rid="bib10"><offsets xml_i="6792" xml_f="6794" txt_i="2019" txt_f="2021">10</offsets></xref></sup><offsets xml_i="6807" xml_f="7143" txt_i="2021" txt_f="2357"> As with all endoscopic procedures, it is important that flexible sigmoidoscopy be done efficiently and with adequate visualization of the bowel. Having an effective cleansing preparation is key to both of these factors. Rectal enemas, usually sodium phosphate based, have been the mainstay of sigmoidoscopy preparations for many years.</offsets><sup><xref ref-type="bibr" rid="bib11"><offsets xml_i="7182" xml_f="7184" txt_i="2357" txt_f="2359">11</offsets></xref><offsets xml_i="7191" xml_f="7193" txt_i="2359" txt_f="2361">, </offsets><xref ref-type="bibr" rid="bib12"><offsets xml_i="7227" xml_f="7229" txt_i="2361" txt_f="2363">12</offsets></xref><offsets xml_i="7236" xml_f="7238" txt_i="2363" txt_f="2365">, </offsets><xref ref-type="bibr" rid="bib13"><offsets xml_i="7272" xml_f="7274" txt_i="2365" txt_f="2367">13</offsets></xref></sup><offsets xml_i="7287" xml_f="7407" txt_i="2367" txt_f="2487"> However, there is a need for better preparations, evidenced by trials looking at oral preparations combined with enemas</offsets><sup><xref ref-type="bibr" rid="bib14"><offsets xml_i="7446" xml_f="7448" txt_i="2487" txt_f="2489">14</offsets></xref><offsets xml_i="7455" xml_f="7457" txt_i="2489" txt_f="2491">, </offsets><xref ref-type="bibr" rid="bib15"><offsets xml_i="7491" xml_f="7493" txt_i="2491" txt_f="2493">15</offsets></xref></sup><offsets xml_i="7506" xml_f="7536" txt_i="2493" txt_f="2523"> or double enema preparations.</offsets><sup><xref ref-type="bibr" rid="bib12"><offsets xml_i="7575" xml_f="7577" txt_i="2523" txt_f="2525">12</offsets></xref><offsets xml_i="7584" xml_f="7586" txt_i="2525" txt_f="2527">, </offsets><xref ref-type="bibr" rid="bib16"><offsets xml_i="7620" xml_f="7622" txt_i="2527" txt_f="2529">16</offsets></xref></sup></p><p><offsets xml_i="7642" xml_f="8360" txt_i="2530" txt_f="3248">Oral preparations have been a mainstay of colon cleansing for colonoscopy as they cleanse the proximal as well as the distal colon and are superior to rectal enemas in this regard. There are three main categories of oral colon cleansing agents: large-volume preparations, small-volume preparations, and a hybrid combination of both. One approach to enhanced cleansing for flexible sigmoidoscopy would be to use a standard colonoscopy cleansing. Although each of these three cleansing regimens can provide adequate cleansing, the large-volume polyethylene-based solutions (polyethylene glycol) solutions are not nearly as well tolerated by patients and can be an obstacle to patients agreeing to undergo investigations.</offsets><sup><xref ref-type="bibr" rid="bib17"><offsets xml_i="8399" xml_f="8401" txt_i="3248" txt_f="3250">17</offsets></xref><offsets xml_i="8408" xml_f="8410" txt_i="3250" txt_f="3252">, </offsets><xref ref-type="bibr" rid="bib18"><offsets xml_i="8444" xml_f="8446" txt_i="3252" txt_f="3254">18</offsets></xref><offsets xml_i="8453" xml_f="8455" txt_i="3254" txt_f="3256">, </offsets><xref ref-type="bibr" rid="bib19"><offsets xml_i="8489" xml_f="8491" txt_i="3256" txt_f="3258">19</offsets></xref><offsets xml_i="8498" xml_f="8500" txt_i="3258" txt_f="3260">, </offsets><xref ref-type="bibr" rid="bib20"><offsets xml_i="8534" xml_f="8536" txt_i="3260" txt_f="3262">20</offsets></xref><offsets xml_i="8543" xml_f="8545" txt_i="3262" txt_f="3264">, </offsets><xref ref-type="bibr" rid="bib21"><offsets xml_i="8579" xml_f="8581" txt_i="3264" txt_f="3266">21</offsets></xref><offsets xml_i="8588" xml_f="8590" txt_i="3266" txt_f="3268">, </offsets><xref ref-type="bibr" rid="bib22"><offsets xml_i="8624" xml_f="8626" txt_i="3268" txt_f="3270">22</offsets></xref><offsets xml_i="8633" xml_f="8635" txt_i="3270" txt_f="3272">, </offsets><xref ref-type="bibr" rid="bib23"><offsets xml_i="8669" xml_f="8671" txt_i="3272" txt_f="3274">23</offsets></xref></sup><offsets xml_i="8684" xml_f="8847" txt_i="3274" txt_f="3437"> In contrast, previous studies have shown that small-volume preparations are well tolerated and much better accepted by patients. Furthermore, our previous studies</offsets><sup><xref ref-type="bibr" rid="bib24"><offsets xml_i="8886" xml_f="8888" txt_i="3437" txt_f="3439">24</offsets></xref></sup><offsets xml_i="8901" xml_f="9165" txt_i="3439" txt_f="3703"> have shown that a single dose (half dose of standard colon cleansing regimen) induces multiple bowel movements and hence could be an ideal adjunct to optimize cleansing for sigmoidoscopy while maintaining patient acceptance of the tolerability of the preparation.</offsets></p><p><offsets xml_i="9172" xml_f="9480" txt_i="3704" txt_f="4012">A few previous studies have attempted to enhance cleansing for flexible sigmoidoscopy using oral preparations, but the results have been variable. Some have shown improved tolerance and cleansing whereas others have shown no difference or even negative results compared with standard sodium phosphate enemas.</offsets><sup><xref ref-type="bibr" rid="bib11"><offsets xml_i="9519" xml_f="9521" txt_i="4012" txt_f="4014">11</offsets></xref><offsets xml_i="9528" xml_f="9530" txt_i="4014" txt_f="4016">, </offsets><xref ref-type="bibr" rid="bib13"><offsets xml_i="9564" xml_f="9566" txt_i="4016" txt_f="4018">13</offsets></xref><offsets xml_i="9573" xml_f="9575" txt_i="4018" txt_f="4020">, </offsets><xref ref-type="bibr" rid="bib14"><offsets xml_i="9609" xml_f="9611" txt_i="4020" txt_f="4022">14</offsets></xref><offsets xml_i="9618" xml_f="9620" txt_i="4022" txt_f="4024">, </offsets><xref ref-type="bibr" rid="bib15"><offsets xml_i="9654" xml_f="9656" txt_i="4024" txt_f="4026">15</offsets></xref><offsets xml_i="9663" xml_f="9665" txt_i="4026" txt_f="4028">, </offsets><xref ref-type="bibr" rid="bib25"><offsets xml_i="9699" xml_f="9701" txt_i="4028" txt_f="4030">25</offsets></xref><offsets xml_i="9708" xml_f="9710" txt_i="4030" txt_f="4032">, </offsets><xref ref-type="bibr" rid="bib26"><offsets xml_i="9744" xml_f="9746" txt_i="4032" txt_f="4034">26</offsets></xref><offsets xml_i="9753" xml_f="9755" txt_i="4034" txt_f="4036">, </offsets><xref ref-type="bibr" rid="bib27"><offsets xml_i="9789" xml_f="9791" txt_i="4036" txt_f="4038">27</offsets></xref></sup><offsets xml_i="9804" xml_f="10255" txt_i="4038" txt_f="4489"> These studies, however, have not examined the combination of a low-volume preparation and a single fleet enema, and we hypothesized that this combination would provide the ideal balance of enhanced efficacy and high patient tolerability. We chose the low-volume preparation sodium picosulfate plus magnesium citrate (P/MC) because recent studies had shown that it was particularly well tolerated compared with polyethylene glycol and sodium phosphate</offsets><sup><xref ref-type="bibr" rid="bib21"><offsets xml_i="10294" xml_f="10296" txt_i="4489" txt_f="4491">21</offsets></xref><offsets xml_i="10303" xml_f="10305" txt_i="4491" txt_f="4493">, </offsets><xref ref-type="bibr" rid="bib28"><offsets xml_i="10339" xml_f="10341" txt_i="4493" txt_f="4495">28</offsets></xref><offsets xml_i="10348" xml_f="10350" txt_i="4495" txt_f="4497">, </offsets><xref ref-type="bibr" rid="bib29"><offsets xml_i="10384" xml_f="10386" txt_i="4497" txt_f="4499">29</offsets></xref></sup><offsets xml_i="10399" xml_f="10559" txt_i="4499" txt_f="4659"> and was also efficacious. Our previous prospective diary studies had shown that a single dose of P/MC stimulated an average of five additional bowel movements.</offsets><sup><xref ref-type="bibr" rid="bib24"><offsets xml_i="10598" xml_f="10600" txt_i="4659" txt_f="4661">24</offsets></xref></sup></p><p><offsets xml_i="10620" xml_f="11086" txt_i="4662" txt_f="5128">To create the necessary comparator groups, the current study examined patient tolerability and efficacy of (1) a single sachet of P/MC (half the recommended colonoscopy dosing recommendation) administered the night before, (2) single sachet of P/MC administered the night before followed by a sodium phosphate enema 1 h before leaving home, and (3) sodium phosphate enema alone administered 1 h before leaving home, for colon cleansing before flexible sigmoidoscopy.</offsets></p></sec><sec><title><offsets xml_i="11108" xml_f="11115" txt_i="5130" txt_f="5137">Methods</offsets></title><sec><title><offsets xml_i="11135" xml_f="11143" txt_i="5138" txt_f="5146">Patients</offsets></title><p><offsets xml_i="11154" xml_f="11671" txt_i="5147" txt_f="5664">Consecutive male and non-pregnant female patients aged 18 years or older who required outpatient flexible sigmoidoscopy at either the Kingston General Hospital or Hotel Dieu Hospital endoscopy units were considered for the study. Exclusion criteria included previous colorectal surgery and patients with reduced renal function (defined as eGFR less than normal range in 3 months before enrollment) or other medical conditions (such as ascites, congestive heart failure) that would increase the risk of receiving P/MC.</offsets></p></sec><sec><title><offsets xml_i="11693" xml_f="11705" txt_i="5666" txt_f="5678">Study design</offsets></title><p><offsets xml_i="11716" xml_f="12019" txt_i="5679" txt_f="5982">The participants undergoing flexible sigmoidoscopy were randomized to one of three separate preparations: (1) one sodium phosphate enema taken 1 h before leaving their home on the day of the procedure (2) one sachet of P/MC (Picosalax Ferring, Ferring Pharmaceuticals, North York, Ontario, Canada) at 7 </offsets><sc><offsets xml_i="12023" xml_f="12025" txt_i="5982" txt_f="5984">pm</offsets></sc><offsets xml_i="12030" xml_f="12113" txt_i="5984" txt_f="6067"> the evening before the procedure and (3) combination of both one sachet P/MC at 7 </offsets><sc><offsets xml_i="12117" xml_f="12119" txt_i="6067" txt_f="6069">pm</offsets></sc><offsets xml_i="12124" xml_f="12265" txt_i="6069" txt_f="6210"> the evening before the procedure and one sodium phosphate enema 1 h before leaving home. No dietary restrictions were given to the patients.</offsets></p><p><offsets xml_i="12272" xml_f="12655" txt_i="6211" txt_f="6594">All the patients were recruited from outpatient gastroenterology clinics with no subjects being seen directly in endoscopy. The patients were consented and randomized by a clinical research assistant who received the assignment by opening an opaque envelope. Randomization was from an independently prepared list with permuted random-size block design (ranging in size from 6 to 12).</offsets></p><p><offsets xml_i="12662" xml_f="12821" txt_i="6595" txt_f="6754">The study was approved by the Queen's University Health Sciences Research Ethics Board and was registered in an international research database (NCT 01554111).</offsets></p></sec><sec><title><offsets xml_i="12843" xml_f="12853" txt_i="6756" txt_f="6766">Statistics</offsets></title><p><offsets xml_i="12864" xml_f="13023" txt_i="6767" txt_f="6926">The primary outcome of the study was efficacy of cleansing, which was measured using the modified Ottawa Bowel Preparation Scale score, a validated instrument.</offsets><sup><xref ref-type="bibr" rid="bib30"><offsets xml_i="13062" xml_f="13064" txt_i="6926" txt_f="6928">30</offsets></xref></sup><offsets xml_i="13077" xml_f="13388" txt_i="6928" txt_f="7239"> The modified scale uses the recto/sigmoid section of the scale. The endoscopist, who was blinded to the cleansing regimen, recorded the score at the end of each procedure. A score of 0 was the best possible score (Excellent) and a score of 4 was representative of an inadequate cleansing for a reasonable exam.</offsets></p><sec><title><offsets xml_i="13404" xml_f="13421" txt_i="7240" txt_f="7257">Power calculation</offsets></title><p><offsets xml_i="13432" xml_f="13846" txt_i="7258" txt_f="7672">Due to the lack of prior data on this scale in sigmoidoscopy, we assumed that the scale is uniformly distributed and the s.d. would be 1.7. This was a conservative estimate. With a within-group s.d. of 1.7, we would require 34 patients in each of the three arms to achieve 90% power using an F-test at an alpha of 0.05. This would be to detect a mean difference of 1.5 points between the highest and lowest groups.</offsets><sup><xref ref-type="bibr" rid="bib31"><offsets xml_i="13885" xml_f="13887" txt_i="7672" txt_f="7674">31</offsets></xref></sup><offsets xml_i="13900" xml_f="13971" txt_i="7674" txt_f="7745"> We assumed a 15% dropout rate, and thus aimed to recruit 120 patients.</offsets></p></sec><sec><title><offsets xml_i="13993" xml_f="14011" txt_i="7747" txt_f="7765">Secondary outcomes</offsets></title><p><offsets xml_i="14022" xml_f="14149" txt_i="7766" txt_f="7893">Each subject completed a tolerance questionnaire when they arrived in the endoscopy suite, used previously in numerous studies.</offsets><sup><xref ref-type="bibr" rid="bib21"><offsets xml_i="14188" xml_f="14190" txt_i="7893" txt_f="7895">21</offsets></xref><offsets xml_i="14197" xml_f="14199" txt_i="7895" txt_f="7897">, </offsets><xref ref-type="bibr" rid="bib32"><offsets xml_i="14233" xml_f="14235" txt_i="7897" txt_f="7899">32</offsets></xref><offsets xml_i="14242" xml_f="14244" txt_i="7899" txt_f="7901">, </offsets><xref ref-type="bibr" rid="bib33"><offsets xml_i="14278" xml_f="14280" txt_i="7901" txt_f="7903">33</offsets></xref><offsets xml_i="14287" xml_f="14289" txt_i="7903" txt_f="7905">, </offsets><xref ref-type="bibr" rid="bib34"><offsets xml_i="14323" xml_f="14325" txt_i="7905" txt_f="7907">34</offsets></xref><offsets xml_i="14332" xml_f="14334" txt_i="7907" txt_f="7909">, </offsets><xref ref-type="bibr" rid="bib35"><offsets xml_i="14368" xml_f="14370" txt_i="7909" txt_f="7911">35</offsets></xref></sup><offsets xml_i="14383" xml_f="14828" txt_i="7911" txt_f="8356"> The questionnaire includes questions regarding acceptability of the bowel preparation (rated on a five-point scale), the patient's compliance with the regimen, and whether the patient would have the same bowel preparation regimen again for another sigmoidoscopy. Specific side effects that were queried via yes or no answers were fecal incontinence, sleep disturbance, abdominal pain, nausea, vomiting, bloating, dizziness, and rectal bleeding.</offsets></p><p><offsets xml_i="14835" xml_f="15102" txt_i="8357" txt_f="8624">Other data collected included the maximum length of scope inserted, whether an additional enema was required to complete an adequate examination, the amount of fluid suctioned during the exam, the Aronchick score for bowel cleansing, and whether polyps were detected.</offsets></p><p><offsets xml_i="15109" xml_f="15312" txt_i="8625" txt_f="8828">Continuous data were analyzed using the analysis of variance, ordinal data with Kruskal–Wallis, and nominal data with chi-square or Fisher's exact test, depending on the number of patients in each group.</offsets></p></sec></sec></sec><sec><title><offsets xml_i="15346" xml_f="15353" txt_i="8832" txt_f="8839">Results</offsets></title><p><offsets xml_i="15364" xml_f="15550" txt_i="8840" txt_f="9026">A total of 120 patients were recruited from the outpatient gastroenterology clinics at Hotel Dieu Hospital between July 2012 and February 2014. Sixteen patients withdrew from the study (</offsets><xref ref-type="fig" rid="fig1"><offsets xml_i="15582" xml_f="15590" txt_i="9026" txt_f="9034">Figure 1</offsets></xref><offsets xml_i="15597" xml_f="15675" txt_i="9034" txt_f="9112">). They withdrew because they no longer wanted to proceed with the procedure (</offsets><italic><offsets xml_i="15683" xml_f="15684" txt_i="9112" txt_f="9113">n</offsets></italic><offsets xml_i="15693" xml_f="15767" txt_i="9113" txt_f="9187">=12), had a change in symptoms resulting in a colonoscopy being arranged (</offsets><italic><offsets xml_i="15775" xml_f="15776" txt_i="9187" txt_f="9188">n</offsets></italic><offsets xml_i="15785" xml_f="15808" txt_i="9188" txt_f="9211">=1), withdrew consent (</offsets><italic><offsets xml_i="15816" xml_f="15817" txt_i="9211" txt_f="9212">n</offsets></italic><offsets xml_i="15826" xml_f="15886" txt_i="9212" txt_f="9272">=2), or chose to have the procedure done at another center (</offsets><italic><offsets xml_i="15894" xml_f="15895" txt_i="9272" txt_f="9273">n</offsets></italic><offsets xml_i="15904" xml_f="16174" txt_i="9273" txt_f="9543">=1). One additional patient was excluded due to missing tolerance and preparation quality data. The data were thus available on 103 patients undergoing sigmoidoscopy by one of six gastroenterologists all of whom were experienced using the Ottawa Bowel Preparation Scale.</offsets><sup><xref ref-type="bibr" rid="bib36"><offsets xml_i="16213" xml_f="16215" txt_i="9543" txt_f="9545">36</offsets></xref></sup></p><p><offsets xml_i="16235" xml_f="16352" txt_i="9546" txt_f="9663">The mean age of the study population was 42 years (range 18–77) and the groups were well matched for age and gender (</offsets><xref rid="tbl1" ref-type="table"><offsets xml_i="16386" xml_f="16393" txt_i="9663" txt_f="9670">Table 1</offsets></xref><offsets xml_i="16400" xml_f="16576" txt_i="9670" txt_f="9846">). Indications for sigmoidoscopy were similar between groups with the large majority being done for rectal bleeding. The majority of patients underwent sigmoidoscopy before 11 </offsets><sc><offsets xml_i="16580" xml_f="16582" txt_i="9846" txt_f="9848">am</offsets></sc><offsets xml_i="16587" xml_f="16714" txt_i="9848" txt_f="9975"> (with no differences in proportions waiting longer between groups) and all were compliant with their preparation instructions.</offsets></p><sec><title><offsets xml_i="16730" xml_f="16738" txt_i="9976" txt_f="9984">Efficacy</offsets></title><p><offsets xml_i="16749" xml_f="16888" txt_i="9985" txt_f="10124">There were no significant differences seen in the preparation quality when assessed by either the modified Ottawa Bowel Preparation Scale (</offsets><italic><offsets xml_i="16896" xml_f="16897" txt_i="10124" txt_f="10125">P</offsets></italic><offsets xml_i="16906" xml_f="16946" txt_i="10125" txt_f="10165">=0.34) or the modified Aronchick scale (</offsets><italic><offsets xml_i="16954" xml_f="16955" txt_i="10165" txt_f="10166">P</offsets></italic><offsets xml_i="16964" xml_f="16971" txt_i="10166" txt_f="10173">=0.13, </offsets><xref ref-type="fig" rid="fig2"><offsets xml_i="17003" xml_f="17011" txt_i="10173" txt_f="10181">Figure 2</offsets></xref><offsets xml_i="17018" xml_f="17289" txt_i="10181" txt_f="10452">). The need for additional enemas was not different between groups, nor was the mean distance reached during sigmoidoscopy (mean=56 cm). Patients in the groups assigned to preparations with P/MC had more fluid suctioned during the exam than those taking the enema alone (</offsets><xref rid="tbl2" ref-type="table"><offsets xml_i="17323" xml_f="17330" txt_i="10452" txt_f="10459">Table 2</offsets></xref><offsets xml_i="17337" xml_f="17339" txt_i="10459" txt_f="10461">).</offsets></p><p><offsets xml_i="17346" xml_f="17438" txt_i="10462" txt_f="10554">Given that the enema-only group did not meet the targeted completion number, we performed a </offsets><italic><offsets xml_i="17446" xml_f="17454" txt_i="10554" txt_f="10562">post hoc</offsets></italic><offsets xml_i="17463" xml_f="17700" txt_i="10562" txt_f="10799"> imputation analysis. The best and worst possible Ottawa and Aronchick scores were imputed for seven additional cases (to match the number of patients in the P/MC group alone). There remained no significant difference between the groups.</offsets></p></sec><sec><title><offsets xml_i="17722" xml_f="17731" txt_i="10801" txt_f="10810">Tolerance</offsets></title><p><offsets xml_i="17742" xml_f="17836" txt_i="10811" txt_f="10905">The majority of patients in each group ranked their preparation regimen as very easy or easy (</offsets><xref ref-type="fig" rid="fig3"><offsets xml_i="17868" xml_f="17876" txt_i="10905" txt_f="10913">Figure 3</offsets></xref><offsets xml_i="17883" xml_f="18062" txt_i="10913" txt_f="11092">) using a five-point global assessment of tolerance ranking the preparation regimen from very easy to very difficult. No significant differences were observed between the groups (</offsets><italic><offsets xml_i="18070" xml_f="18071" txt_i="11092" txt_f="11093">P</offsets></italic><offsets xml_i="18080" xml_f="18490" txt_i="11093" txt_f="11503">=0.46). In addition, greater than 90% of patients in each group said that they would take their assigned preparation again in the future. However, there were some differences in the experiences of patients taking the preparations. The patients in the groups taking P/MC were more likely to report nausea (although no difference in vomiting was seen), bloating, abdominal pain, dizziness, and trouble sleeping (</offsets><xref rid="tbl3" ref-type="table"><offsets xml_i="18524" xml_f="18531" txt_i="11503" txt_f="11510">Table 3</offsets></xref><offsets xml_i="18538" xml_f="18625" txt_i="11510" txt_f="11597">). Despite this, no adverse events or serious adverse events occurred during the study.</offsets></p></sec></sec><sec><title><offsets xml_i="18653" xml_f="18663" txt_i="11600" txt_f="11610">Discussion</offsets></title><p><offsets xml_i="18674" xml_f="19873" txt_i="11611" txt_f="12810">The major advantages of flexible sigmoidoscopy are that it can be completed more quickly than colonoscopy and it requires no sedation. As a result, shorter booking intervals enable more cases to be completed during the daily endoscopy schedule. However, if the cleansing is poor, a second enema is often administered in the endoscopy suite resulting in significant delays and disruption to the schedule. Alternatively, the patients would be re-booked causing further delays in the diagnosis and treatment as well as greater use of resources. Despite the intuitive advantage of adding an oral cleansing supplement to the standard fleet enema to overcome these issues, we found no differences in efficacy between the three preparations—oral P/MC, oral P/MC plus sodium phosphate enema, or sodium phosphate enema alone. The reasons for this are unclear, but one possible explanation is that oral preparation advances stool from the right colon to the left, and paradoxically does not diminish the burden of stool for the enema to clear. Another reason for this may be the timing of the preparations, as evidence now firmly supports administering colonoscopy preparation within 4–6 h of the exam itself.</offsets><sup><xref ref-type="bibr" rid="bib37"><offsets xml_i="19912" xml_f="19914" txt_i="12810" txt_f="12812">37</offsets></xref></sup><offsets xml_i="19927" xml_f="20077" txt_i="12812" txt_f="12962"> Whether this principle applies to sigmoidoscopy is not yet determined, given the partial cleansing provided, but will be worth investigating further.</offsets></p><p><offsets xml_i="20084" xml_f="20200" txt_i="12963" txt_f="13079">Our results differ from several previous studies that reported better tolerance of the oral preparation than enemas.</offsets><sup><xref ref-type="bibr" rid="bib11"><offsets xml_i="20239" xml_f="20241" txt_i="13079" txt_f="13081">11</offsets></xref><offsets xml_i="20248" xml_f="20250" txt_i="13081" txt_f="13083">, </offsets><xref ref-type="bibr" rid="bib13"><offsets xml_i="20284" xml_f="20286" txt_i="13083" txt_f="13085">13</offsets></xref><offsets xml_i="20293" xml_f="20295" txt_i="13085" txt_f="13087">, </offsets><xref ref-type="bibr" rid="bib15"><offsets xml_i="20329" xml_f="20331" txt_i="13087" txt_f="13089">15</offsets></xref><offsets xml_i="20338" xml_f="20340" txt_i="13089" txt_f="13091">, </offsets><xref ref-type="bibr" rid="bib25"><offsets xml_i="20374" xml_f="20376" txt_i="13091" txt_f="13093">25</offsets></xref><offsets xml_i="20383" xml_f="20385" txt_i="13093" txt_f="13095">, </offsets><xref ref-type="bibr" rid="bib26"><offsets xml_i="20419" xml_f="20421" txt_i="13095" txt_f="13097">26</offsets></xref></sup><offsets xml_i="20434" xml_f="20799" txt_i="13097" txt_f="13462"> There are several potential explanations for this. One is that patients recruited to the current study provided consent before enrollment (unlike several other studies), and were informed of the fact that there would be enemas in the two arms of the trial. Thus, the people enrolled into the current study were already prepared to use an enema, if required. Atkin </offsets><italic><offsets xml_i="20807" xml_f="20813" txt_i="13462" txt_f="13468">et al.</offsets></italic><sup><xref ref-type="bibr" rid="bib27"><offsets xml_i="20861" xml_f="20863" txt_i="13468" txt_f="13470">27</offsets></xref></sup><offsets xml_i="20876" xml_f="20999" txt_i="13470" txt_f="13593"> randomized patients taking part in a larger trial but the patients were unaware of the intervention arms. Similarly, Bini </offsets><italic><offsets xml_i="21007" xml_f="21013" txt_i="13593" txt_f="13599">et al.</offsets></italic><sup><xref ref-type="bibr" rid="bib15"><offsets xml_i="21061" xml_f="21063" txt_i="13599" txt_f="13601">15</offsets></xref></sup><offsets xml_i="21076" xml_f="21404" txt_i="13601" txt_f="13929"> randomized all patients referred without consenting them to the study, thus potentially including patients who would normally refuse an enema. Thus, the design of the current study is more likely to assess the true tolerance of the preparations, as opposed to pre-study biases of patients against certain agents such as enemas.</offsets><sup><xref ref-type="bibr" rid="bib38"><offsets xml_i="21443" xml_f="21445" txt_i="13929" txt_f="13931">38</offsets></xref><offsets xml_i="21452" xml_f="21454" txt_i="13931" txt_f="13933">, </offsets><xref ref-type="bibr" rid="bib39"><offsets xml_i="21488" xml_f="21490" txt_i="13933" txt_f="13935">39</offsets></xref></sup><offsets xml_i="21503" xml_f="21687" txt_i="13935" txt_f="14119"> Nonetheless, there were aspects of the current study that could have influenced the tolerability and efficacy scores. For example, timing of preparation may have been a factor. Atkin </offsets><italic><offsets xml_i="21695" xml_f="21701" txt_i="14119" txt_f="14125">et al.</offsets></italic><offsets xml_i="21710" xml_f="22386" txt_i="14125" txt_f="14801"> used an earlier time point in the day to administer P/MC and thus patients likely experienced less sleep disturbance. Similarly timing of the enema dosing has varied between the studies. In several studies, it was administered 1 h before the exam, often by a health-care professional, whereas in the current study, patients self-administered it 1 h before leaving the house. This may have increased patient tolerance of the enema but could also have resulted in poorer preparations if there was a delay between the scheduled time of the sigmoidoscopy and the real start time. However, other studies have varied the timing of the enemas as well as administered a second enema,</offsets><sup><xref ref-type="bibr" rid="bib12"><offsets xml_i="22425" xml_f="22427" txt_i="14801" txt_f="14803">12</offsets></xref><offsets xml_i="22434" xml_f="22436" txt_i="14803" txt_f="14805">, </offsets><xref ref-type="bibr" rid="bib14"><offsets xml_i="22470" xml_f="22472" txt_i="14805" txt_f="14807">14</offsets></xref><offsets xml_i="22479" xml_f="22481" txt_i="14807" txt_f="14809">, </offsets><xref ref-type="bibr" rid="bib16"><offsets xml_i="22515" xml_f="22517" txt_i="14809" txt_f="14811">16</offsets></xref><offsets xml_i="22524" xml_f="22526" txt_i="14811" txt_f="14813">, </offsets><xref ref-type="bibr" rid="bib25"><offsets xml_i="22560" xml_f="22562" txt_i="14813" txt_f="14815">25</offsets></xref></sup><offsets xml_i="22575" xml_f="22775" txt_i="14815" txt_f="15015"> with no major differences observed. All the exams in this study were scheduled for the morning, but the use of a morning dose of oral purgative may be worth investigating for afternoon sigmoidoscopy.</offsets></p><p><offsets xml_i="22782" xml_f="23350" txt_i="15016" txt_f="15584">The study design did have some advantages compared with several previous studies, including the one-on-one patient instruction, consent process, intention to treat analysis, and power to detect clinically significant differences. There was a dropout rate (13.3%), mostly attributable to people deciding against undergoing the test. In our experience, this is not uncommon, especially when relatively minor symptoms such as rectal bleeding have resolved in younger patients. In fact, compared with other studies, the dropout rate was better than that described in many.</offsets><sup><xref ref-type="bibr" rid="bib16"><offsets xml_i="23389" xml_f="23391" txt_i="15584" txt_f="15586">16</offsets></xref><offsets xml_i="23398" xml_f="23400" txt_i="15586" txt_f="15588">, </offsets><xref ref-type="bibr" rid="bib40"><offsets xml_i="23434" xml_f="23436" txt_i="15588" txt_f="15590">40</offsets></xref></sup><offsets xml_i="23449" xml_f="24084" txt_i="15590" txt_f="16225"> Given that all the flexible sigmoidoscopies in this study were conducted in the morning, it would be inappropriate to draw conclusions about afternoon exams; but given the longer delay between the evening before P/MC ingestion and the exam, it is difficult to hypothesize that cleansing would be enhanced. The current study also differs from others in the age of the study population as well. A majority of the patients in this study were undergoing sigmoidoscopy as an investigation of symptoms as opposed to as a screening procedure, and thus the mean age was 42 years compared with the older screening populations of other studies.</offsets><sup><xref ref-type="bibr" rid="bib15"><offsets xml_i="24123" xml_f="24125" txt_i="16225" txt_f="16227">15</offsets></xref><offsets xml_i="24132" xml_f="24134" txt_i="16227" txt_f="16229">, </offsets><xref ref-type="bibr" rid="bib25"><offsets xml_i="24168" xml_f="24170" txt_i="16229" txt_f="16231">25</offsets></xref><offsets xml_i="24177" xml_f="24179" txt_i="16231" txt_f="16233">, </offsets><xref ref-type="bibr" rid="bib27"><offsets xml_i="24213" xml_f="24215" txt_i="16233" txt_f="16235">27</offsets></xref></sup><offsets xml_i="24228" xml_f="24363" txt_i="16235" txt_f="16370"> Given the results of the current study, it is unlikely that older age would positively impact either the tolerability or the efficacy.</offsets></p><p><offsets xml_i="24370" xml_f="24747" txt_i="16371" txt_f="16748">In conclusion, when an oral low-volume colon cleansing agent is administered alone or as an adjunct to standard fleet enema for distal bowel cleansing, the oral preparation did not improve the quality of colon cleansing. Furthermore, although well tolerated, the oral preparation was associated with more side effects, such as nausea, abdominal bloating, and sleep disturbance.</offsets></p></sec><sec><title><offsets xml_i="24769" xml_f="24790" txt_i="16750" txt_f="16771">Translation statement</offsets></title><p><offsets xml_i="24801" xml_f="25030" txt_i="16772" txt_f="17001">The results of this clinical trial demonstrate that improvement in the efficacy of preparation for flexible sigmoidoscopy is not achieved through the addition of agents, and efforts should focus on education and timing of enemas.</offsets></p></sec><sec><title><offsets xml_i="25052" xml_f="25068" txt_i="17003" txt_f="17019">Study Highlights</offsets></title><p><inline-graphic xlink:href="ctg201615i1.jpg"></inline-graphic></p></sec></body><back><ack><p>We thank Jackie McKay and Darlene Brady for their invaluable assistance in conducting the study.</p></ack><fn-group><fn fn-type="conflict"><p><bold>Guarantor of the article</bold>: Lawrence Hookey, MD.</p><p><bold>Specific author contributions</bold>: Lawrence Hookey: conception of study, development of protocol, data collection, data analysis, and drafting of manuscript. He approves the final version of the manuscript. Samson Haimonot: conception of study, development of protocol, data collection, data analysis, and drafting of manuscript. He approves the final version of the manuscript. Katherine Marchut: data collection, data analysis, and drafting of manuscript. She approves the final version of the manuscript. Stephen Vanner: conception of study, development of protocol, data collection, data analysis, and drafting of manuscript. He approves the final version of the manuscript.</p><p><bold>Financial support</bold>: This study was internally funded. There were no study sponsors.</p><p><bold>Potential competing interests</bold>: Drs Vanner and Hookey have received research support and consulting fees from Ferring Pharmaceuticals, makers of sodium picosulfate and magnesium citrate.</p></fn></fn-group><ref-list><ref id="bib1"><mixed-citation publication-type="journal">Patel R, Clancy R, Crowther E et al. <article-title>A rectal bleeding algorithm can successfully reduce emergency admissions</article-title>. <source>Colorectal Dis</source>
<year>2014</year>; <volume>16</volume>: <fpage>377</fpage>–381.<pub-id pub-id-type="pmid">24354580</pub-id></mixed-citation></ref><ref id="bib2"><mixed-citation publication-type="journal">Andreyev HJ, Vlavianos P, Blake P et al. <article-title>Gastrointestinal symptoms after pelvic radiotherapy: role for the gastroenterologist</article-title>? <source>Int J Radiat Oncol Biol Phys</source>
<year>2005</year>; <volume>62</volume>: <fpage>1464</fpage>–1471.<pub-id pub-id-type="pmid">15927411</pub-id></mixed-citation></ref><ref id="bib3"><mixed-citation publication-type="other">Harris A. <article-title>Guidance on the indications for diagnostic upper GI endoscopy, flexible sigmoidoscopy, and colonoscopy</article-title><year>2013</year>. Available at: http://www.bsg.org.uk/clinical-guidance/endoscopy/guidance-on-the-indications-for-diagnostic-upper-gi-endoscopy-flexible-sigmoidoscopy-and-colonoscopy.html.</mixed-citation></ref><ref id="bib4"><mixed-citation publication-type="other">UK Department of Health. <article-title>Improving Outcomes: a strategy for cancer</article-title><year>2010</year>. Available at: https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/213785/dh_123394.pdf.</mixed-citation></ref><ref id="bib5"><mixed-citation publication-type="journal">Holme O, Loberg M, Kalager M et al. <article-title>Effect of flexible sigmoidoscopy screening on colorectal cancer incidence and mortality: a randomized clinical trial</article-title>. <source>JAMA</source>
<year>2014</year>; <volume>312</volume>: <fpage>606</fpage>–615.<pub-id pub-id-type="pmid">25117129</pub-id></mixed-citation></ref><ref id="bib6"><mixed-citation publication-type="journal">Brenner H, Stock C, Hoffmeister M. <article-title>Effect of screening sigmoidoscopy and screening colonoscopy on colorectal cancer incidence and mortality: systematic review and meta-analysis of randomised controlled trials and observational studies</article-title>. <source>BMJ</source>
<year>2014</year>; <volume>348</volume>: <fpage>g2467</fpage>.<pub-id pub-id-type="pmid">24922745</pub-id></mixed-citation></ref><ref id="bib7"><mixed-citation publication-type="journal">Schoen RE, Pinsky PF, Weissfeld JL et al. <article-title>Colorectal-cancer incidence and mortality with screening flexible sigmoidoscopy</article-title>. <source>N Engl J Med</source>
<year>2012</year>; <volume>366</volume>: <fpage>2345</fpage>–2357.<pub-id pub-id-type="pmid">22612596</pub-id></mixed-citation></ref><ref id="bib8"><mixed-citation publication-type="journal">Atkin WS, Edwards R, Kralj-Hans I et al. <article-title>Once-only flexible sigmoidoscopy screening in prevention of colorectal cancer: a multicentre randomised controlled trial</article-title>. <source>Lancet</source>
<year>2010</year>; <volume>375</volume>: <fpage>1624</fpage>–1633.<pub-id pub-id-type="pmid">20430429</pub-id></mixed-citation></ref><ref id="bib9"><mixed-citation publication-type="journal">Leddin DJ, Enns R, Hilsden R et al. <article-title>Canadian Association of Gastroenterology position statement on screening individuals at average risk for developing colorectal cancer: 2010</article-title>. <source>Can J Gastroenterol</source>
<year>2010</year>; <volume>24</volume>: <fpage>705</fpage>–714.<pub-id pub-id-type="pmid">21165377</pub-id></mixed-citation></ref><ref id="bib10"><mixed-citation publication-type="journal">Segnan N, Armaroli P, Bonelli L et al. <article-title>Once-only sigmoidoscopy in colorectal cancer screening: follow-up findings of the Italian Randomized Controlled Trial—SCORE</article-title>. <source>J Natl Cancer Inst</source>
<year>2011</year>; <volume>103</volume>: <fpage>1310</fpage>–1322.<pub-id pub-id-type="pmid">21852264</pub-id></mixed-citation></ref><ref id="bib11"><mixed-citation publication-type="journal">Hickson DE, Cox JG, Taylor RG et al. <article-title>Enema or Picolax as preparation for flexible sigmoidoscopy</article-title>? <source>Postgrad Med J</source>
<year>1990</year>; <volume>66</volume>: <fpage>210</fpage>–211.<pub-id pub-id-type="pmid">2194188</pub-id></mixed-citation></ref><ref id="bib12"><mixed-citation publication-type="journal">Preston KL, Peluso FE, Goldner F. <article-title>Optimal bowel preparation for flexible sigmoidoscopy—are two enemas better than one</article-title>? <source>Gastrointest Endosc</source>
<year>1994</year>; <volume>40</volume>: <fpage>474</fpage>–476.<pub-id pub-id-type="pmid">7926539</pub-id></mixed-citation></ref><ref id="bib13"><mixed-citation publication-type="journal">Sharma VK, Chockalingham S, Clark V et al. <article-title>Randomized, controlled comparison of two forms of preparation for screening flexible sigmoidoscopy</article-title>. <source>Am J Gastroenterol</source>
<year>1997</year>; <volume>92</volume>: <fpage>809</fpage>–811.<pub-id pub-id-type="pmid">9149190</pub-id></mixed-citation></ref><ref id="bib14"><mixed-citation publication-type="journal">Osgard E, Jackson JL, Strong J. <article-title>A randomized trial comparing three methods of bowel preparation for flexible sigmoidoscopy</article-title>. <source>Am J Gastroenterol</source>
<year>1998</year>; <volume>93</volume>: <fpage>1126</fpage>–1130.<pub-id pub-id-type="pmid">9672343</pub-id></mixed-citation></ref><ref id="bib15"><mixed-citation publication-type="journal">Bini EJ, Unger JS, Rieber JM et al. <article-title>Prospective, randomized, single-blind comparison of two preparations for screening flexible sigmoidoscopy</article-title>. <source>Gastrointest Endosc</source>
<year>2000</year>; <volume>52</volume>: <fpage>218</fpage>–222.<pub-id pub-id-type="pmid"></pub-id></mixed-citation></ref><ref id="bib16"><mixed-citation publication-type="journal">Gidwani AL, Makar R, Garrett D et al. <article-title>A prospective randomized single-blind comparison of three methods of bowel preparation for outpatient flexible sigmoidoscopy</article-title>. <source>Surg Endosc</source>
<year>2007</year>; <volume>21</volume>: <fpage>945</fpage>–949.<pub-id pub-id-type="pmid">17149552</pub-id></mixed-citation></ref><ref id="bib17"><mixed-citation publication-type="journal">Brown AR, DiPalma JA. <article-title>Bowel preparation for gastrointestinal procedures</article-title>. <source>Curr Gastroenterol Rep</source>
<year>2004</year>; <volume>6</volume>: <fpage>395</fpage>–401.<pub-id pub-id-type="pmid">15341716</pub-id></mixed-citation></ref><ref id="bib18"><mixed-citation publication-type="journal">DiPalma JA, Wolff BG, Meagher A et al. <article-title>Comparison of reduced volume versus four liters sulfate-free electrolyte lavage solutions for colonoscopy colon cleansing</article-title>. <source>Am J Gastroenterol</source>
<year>2003</year>; <volume>98</volume>: <fpage>2187</fpage>–2191.<pub-id pub-id-type="pmid">14572566</pub-id></mixed-citation></ref><ref id="bib19"><mixed-citation publication-type="journal">Frommer D. <article-title>Cleansing ability and tolerance of three bowel preparations for colonoscopy</article-title>. <source>Dis Colon Rectum</source>
<year>1997</year>; <volume>40</volume>: <fpage>100</fpage>–104.<pub-id pub-id-type="pmid">9102248</pub-id></mixed-citation></ref><ref id="bib20"><mixed-citation publication-type="journal">Hamilton D, Mulcahy D, Walsh D et al. <article-title>Sodium picosulphate compared with polyethylene glycol solution for large bowel lavage: a prospective randomised trial</article-title>. <source>Br J Clin Pract</source>
<year>1996</year>; <volume>50</volume>: <fpage>73</fpage>–75.<pub-id pub-id-type="pmid">8731641</pub-id></mixed-citation></ref><ref id="bib21"><mixed-citation publication-type="journal">Hookey LC, Vanner SJ. <article-title>Pico-salax plus two-day bisacodyl is superior to pico-salax alone or oral sodium phosphate for colon cleansing before colonoscopy</article-title>. <source>Am J Gastroenterol</source>
<year>2009</year>; <volume>104</volume>: <fpage>703</fpage>–709.<pub-id pub-id-type="pmid">19223885</pub-id></mixed-citation></ref><ref id="bib22"><mixed-citation publication-type="journal">Tan JJ, Tjandra JJ. <article-title>Which is the optimal bowel preparation for colonoscopy - a meta-analysis</article-title>. <source>Colorectal Dis</source>
<year>2006</year>; <volume>8</volume>: <fpage>247</fpage>–258.<pub-id pub-id-type="pmid">16630226</pub-id></mixed-citation></ref><ref id="bib23"><mixed-citation publication-type="journal">Toledo TK, DiPalma JA. <article-title>Review article: colon cleansing preparation for gastrointestinal procedures</article-title>. <source>Aliment Pharmacol Ther</source>
<year>2001</year>; <volume>15</volume>: <fpage>605</fpage>–611.<pub-id pub-id-type="pmid">11328253</pub-id></mixed-citation></ref><ref id="bib24"><mixed-citation publication-type="journal">Vanner S, Hookey LC. <article-title>Timing and frequency of bowel activity in patients ingesting sodium picosulphate/magnesium citrate and adjuvant bisacodyl for colon cleansing before colonoscopy</article-title>. <source>Can J Gastroenterol</source>
<year>2011</year>; <volume>25</volume>: <fpage>663</fpage>–666.<pub-id pub-id-type="pmid">22175056</pub-id></mixed-citation></ref><ref id="bib25"><mixed-citation publication-type="journal">Fincher RK, Osgard EM, Jackson JL et al. <article-title>A comparison of bowel preparations for flexible sigmoidoscopy: oral magnesium citrate combined with oral bisacodyl, one hypertonic phosphate enema, or two hypertonic phosphate enemas</article-title>. <source>Am J Gastroenterol</source>
<year>1999</year>; <volume>94</volume>: <fpage>2122</fpage>–2127.<pub-id pub-id-type="pmid">10445538</pub-id></mixed-citation></ref><ref id="bib26"><mixed-citation publication-type="journal">Forster JA, Thomas WM. <article-title>Patient preferences and side effects experienced with oral bowel preparations versus self-administered phosphate enema</article-title>. <source>Ann R Coll Surg Engl</source>
<year>2003</year>; <volume>85</volume>: <fpage>185</fpage>–186.<pub-id pub-id-type="pmid">12831492</pub-id></mixed-citation></ref><ref id="bib27"><mixed-citation publication-type="journal">Atkin WS, Hart A, Edwards R et al. <article-title>Single blind, randomised trial of efficacy and acceptability of oral picolax versus self administered phosphate enema in bowel preparation for flexible sigmoidoscopy screening</article-title>. <source>BMJ</source>
<year>2000</year>; <volume>320</volume>: <fpage>1504</fpage>–1508.<pub-id pub-id-type="pmid">10834891</pub-id></mixed-citation></ref><ref id="bib28"><mixed-citation publication-type="journal">Rex DK, Katz PO, Bertiger G et al. <article-title>Split-dose administration of a dual-action, low-volume bowel cleanser for colonoscopy: the SEE CLEAR I study</article-title>. <source>Gastrointest Endosc</source>
<year>2013</year>; <volume>78</volume>: <fpage>132</fpage>–141.<pub-id pub-id-type="pmid">23566639</pub-id></mixed-citation></ref><ref id="bib29"><mixed-citation publication-type="journal">Katz PO, Rex DK, Epstein M et al. <article-title>A dual-action, low-volume bowel cleanser administered the day before colonoscopy: results from the SEE CLEAR II study</article-title>. <source>Am J Gastroenterol</source>
<year>2013</year>; <volume>108</volume>: <fpage>401</fpage>–409.<pub-id pub-id-type="pmid">23318484</pub-id></mixed-citation></ref><ref id="bib30"><mixed-citation publication-type="journal">Rostom A, Jolicoeur E. <article-title>Validation of a new scale for the assessment of bowel preparation quality</article-title>. <source>Gastrointest Endosc</source>
<year>2004</year>; <volume>59</volume>: <fpage>482</fpage>–486.<pub-id pub-id-type="pmid">15044882</pub-id></mixed-citation></ref><ref id="bib31"><mixed-citation publication-type="journal">Rostom A, Jolicoeur E, Dube C et al. <article-title>A randomized prospective trial comparing different regimens of oral sodium phosphate and polyethylene glycol-based lavage solution in the preparation of patients for colonoscopy</article-title>. <source>Gastrointest Endosc</source>
<year>2006</year>; <volume>64</volume>: <fpage>544</fpage>–552.<pub-id pub-id-type="pmid">16996347</pub-id></mixed-citation></ref><ref id="bib32"><mixed-citation publication-type="journal">Barclay RL, Depew WT, Vanner SJ. <article-title>Carbohydrate-electrolyte rehydration protects against intravascular volume contraction during colonic cleansing with orally administered sodium phosphate</article-title>. <source>Gastrointest Endosc</source>
<year>2002</year>; <volume>56</volume>: <fpage>633</fpage>–638.<pub-id pub-id-type="pmid">12397268</pub-id></mixed-citation></ref><ref id="bib33"><mixed-citation publication-type="journal">Chan A, Depew W, Vanner S. <article-title>Use of oral sodium phosphate colonic lavage solution by Canadian colonoscopists: pitfalls and complications</article-title>. <source>Can J Gastroenterol</source>
<year>1997</year>; <volume>11</volume>: <fpage>334</fpage>–338.<pub-id pub-id-type="pmid">9218859</pub-id></mixed-citation></ref><ref id="bib34"><mixed-citation publication-type="journal">Flemming JA, Vanner SJ, Hookey LC. <article-title>Split-dose picosulfate, magnesium oxide, and citric acid solution markedly enhances colon cleansing before colonoscopy: a randomized, controlled trial</article-title>. <source>Gastrointest Endosc</source>
<year>2012</year>; <volume>75</volume>: <fpage>537</fpage>–544.<pub-id pub-id-type="pmid">22192423</pub-id></mixed-citation></ref><ref id="bib35"><mixed-citation publication-type="journal">Hookey LC, Depew WT, Vanner SJ. <article-title>A prospective randomized trial comparing low-dose oral sodium phosphate plus stimulant laxatives with large volume polyethylene glycol solution for colon cleansing</article-title>. <source>Am J Gastroenterol</source>
<year>2004</year>; <volume>99</volume>: <fpage>2217</fpage>–2222.<pub-id pub-id-type="pmid">15555005</pub-id></mixed-citation></ref><ref id="bib36"><mixed-citation publication-type="journal">McKnight LC, Day AG, Hookey LC. <article-title>A formal assessment of the need for teaching prior to the use of the Ottawa Bowel Preparation Scale</article-title>. <source>Am J Gastroenterol</source>
<year>2006</year>; <volume>101</volume>: <fpage>s508</fpage>.</mixed-citation></ref><ref id="bib37"><mixed-citation publication-type="journal">Rex DK. <article-title>Bowel preparation for colonoscopy: entering an era of increased expectations for efficacy</article-title>. <source>Clin Gastroenterol Hepatol</source>
<year>2014</year>; <volume>12</volume>: <fpage>458</fpage>–462.<pub-id pub-id-type="pmid">24239858</pub-id></mixed-citation></ref><ref id="bib38"><mixed-citation publication-type="journal">Wulff H. <article-title>Commentary: participants should have been told they were being randomised</article-title>. <source>BMJ</source>
<year>2010</year>; <volume>320</volume>: <fpage>1509</fpage>.</mixed-citation></ref><ref id="bib39"><mixed-citation publication-type="journal">Taylor M. <article-title>Commentary: opportunity for patient partnership was lost</article-title>. <source>BMJ</source>
<year>2010</year>; <volume>320</volume>: <fpage>1509</fpage>.</mixed-citation></ref><ref id="bib40"><mixed-citation publication-type="journal">Underwood D, Makar RR, Gidwani AL et al. <article-title>A prospective randomized single blind trial of Fleet phosphate enema versus glycerin suppositories as preparation for flexible sigmoidoscopy</article-title>. <source>Ir J Med Sci</source>
<year>2010</year>; <volume>179</volume>: <fpage>113</fpage>–118.<pub-id pub-id-type="pmid">19655226</pub-id></mixed-citation></ref></ref-list></back><floats-group><fig id="fig1"><label>Figure 1</label><caption><p>Patient flow through study. P/MC, sodium picosulfate plus magnesium citrate.</p></caption><graphic xlink:href="ctg201615f1"></graphic></fig><fig id="fig2"><label>Figure 2</label><caption><p>Bowel cleansing results as per the Modified Ottawa Bowel Preparation Scale. P/MC, sodium picosulfate plus magnesium citrate.</p></caption><graphic xlink:href="ctg201615f2"></graphic></fig><fig id="fig3"><label>Figure 3</label><caption><p>Tolerability of preparations. P/MC, sodium picosulfate plus magnesium citrate.</p></caption><graphic xlink:href="ctg201615f3"></graphic></fig><table-wrap id="tbl1"><label>Table 1</label><caption><title>Patient demographics and technical results of flexible sigmoidoscopy</title></caption><table frame="hsides" rules="groups" border="1"><colgroup><col align="left"></col><col align="center"></col><col align="center"></col><col align="center"></col><col align="char" char="."></col></colgroup><thead valign="bottom"><tr><th align="left" valign="top" charoff="50"> </th><th colspan="3" align="center" valign="top" charoff="50"><bold>Group</bold><hr></hr></th><th align="center" valign="top" char="." charoff="50"><italic><bold>P</bold></italic>-<bold>value</bold></th></tr><tr><th align="left" valign="top" charoff="50"> </th><th align="center" valign="top" charoff="50"><bold>P/MC alone</bold>
<bold>(</bold><italic><bold>n</bold></italic><bold>=36)</bold></th><th align="center" valign="top" charoff="50"><bold>P/MC plus</bold>
<bold>sodium phosphate</bold>
<bold>enema (</bold><italic><bold>n</bold></italic><bold>=38)</bold></th><th align="center" valign="top" charoff="50"><bold>Sodium phosphate</bold>
<bold>enema alone (</bold><italic><bold>n</bold></italic><bold>=29)</bold></th><th align="char" valign="top" char="." charoff="50"> </th></tr></thead><tbody valign="top"><tr><td align="left" valign="top" charoff="50">Age (mean plus range)</td><td align="center" valign="top" charoff="50">44.4 (20–74)</td><td align="center" valign="top" charoff="50">39.6 (18–77)</td><td align="center" valign="top" charoff="50">43.2 (20–65)</td><td align="char" valign="top" char="." charoff="50">0.38</td></tr><tr><td align="left" valign="top" charoff="50">Male (percentage)</td><td align="center" valign="top" charoff="50">36</td><td align="center" valign="top" charoff="50">63</td><td align="center" valign="top" charoff="50">55</td><td align="char" valign="top" char="." charoff="50">0.06</td></tr><tr><td colspan="5" align="left" valign="top" charoff="50"> </td></tr><tr><td colspan="5" align="left" valign="top" charoff="50"><italic>Indication for sigmoidoscopy</italic></td></tr><tr><td align="left" valign="top" charoff="50"> Rectal bleeding</td><td align="center" valign="top" charoff="50">28</td><td align="center" valign="top" charoff="50">28</td><td align="center" valign="top" charoff="50">24</td><td align="char" valign="top" char="." charoff="50">0.60</td></tr><tr><td align="left" valign="top" charoff="50"> Diarrhea</td><td align="center" valign="top" charoff="50">3</td><td align="center" valign="top" charoff="50">0</td><td align="center" valign="top" charoff="50">0</td><td align="char" valign="top" char="." charoff="50"> </td></tr><tr><td align="left" valign="top" charoff="50"> Other (weight loss, incontinence, abnormal CT, rectal pain, proctitis)</td><td align="center" valign="top" charoff="50">5</td><td align="center" valign="top" charoff="50">10</td><td align="center" valign="top" charoff="50">5</td><td align="char" valign="top" char="." charoff="50"> </td></tr><tr><td> </td><td colspan="2" align="left" valign="top" charoff="50"> </td><td align="center" valign="top" charoff="50"> </td><td align="center" valign="top" char="." charoff="50"> </td><td align="char" valign="top" char="." charoff="50"> </td></tr><tr><td align="left" valign="top" charoff="50">Insertion depth of exam (mean (cm)±s.d.)</td><td align="center" valign="top" charoff="50">56 (±14)</td><td align="center" valign="top" charoff="50">54 (±12)</td><td align="center" valign="top" charoff="50">55 (±17)</td><td align="char" valign="top" char="." charoff="50">0.87</td><td> </td></tr><tr><td align="left" valign="top" charoff="50">Polyps detected (% of patients)</td><td align="center" valign="top" charoff="50">17</td><td align="center" valign="top" charoff="50">18</td><td align="center" valign="top" charoff="50">21</td><td align="char" valign="top" char="." charoff="50">0.91</td><td> </td></tr></tbody></table><table-wrap-foot><fn id="t1-fn1"><p>CT, computed tomography; P/MC, sodium picosulfate plus magnesium citrate.</p></fn></table-wrap-foot></table-wrap><table-wrap id="tbl2"><label>Table 2</label><caption><title>Sigmoidoscopy cleanliness data</title></caption><table frame="hsides" rules="groups" border="1"><colgroup><col align="left"></col><col align="center"></col><col align="center"></col><col align="center"></col><col align="char" char="."></col></colgroup><thead valign="bottom"><tr><th align="left" valign="top" charoff="50"> </th><th colspan="3" align="center" valign="top" charoff="50"><bold>Group</bold><hr></hr></th><th align="center" valign="top" char="." charoff="50"><italic><bold>P</bold></italic>-<bold>value</bold></th></tr><tr><th align="left" valign="top" charoff="50"> </th><th align="center" valign="top" charoff="50"><bold>P/MC alone</bold>
<bold>(</bold><italic><bold>n</bold></italic><bold>=36)</bold></th><th align="center" valign="top" charoff="50"><bold>P/MC plus</bold>
<bold>sodium phosphate enema</bold>
<bold>(</bold><italic><bold>n</bold></italic><bold>=38)</bold></th><th align="center" valign="top" charoff="50"><bold>Sodium phosphate enema</bold>
<bold>alone (</bold><italic><bold>n</bold></italic><bold>=29)</bold></th><th align="char" valign="top" char="." charoff="50"> </th></tr></thead><tbody valign="top"><tr><td align="left" valign="top" charoff="50">Mean Modified Ottawa Bowel Prep Score</td><td align="center" valign="top" charoff="50">1.92 (s.d.=1.2)</td><td align="center" valign="top" charoff="50">1.54 (s.d.=1.3)</td><td align="center" valign="top" charoff="50">1.50 (s.d.=1.2)</td><td align="char" valign="top" char="." charoff="50">0.30</td></tr><tr><td align="left" valign="top" charoff="50">Preparation rated good or excellent Ottawa Bowel Prep Score (% of patients)</td><td align="center" valign="top" charoff="50">41.7</td><td align="center" valign="top" charoff="50">56.8</td><td align="center" valign="top" charoff="50">57.1</td><td align="char" valign="top" char="." charoff="50">0.34</td></tr><tr><td align="left" valign="top" charoff="50">Amount of fluid suctioned during exam</td><td align="center" valign="top" charoff="50">143 ml (±191)</td><td align="center" valign="top" charoff="50">106 ml (±124)</td><td align="center" valign="top" charoff="50">47 ml (±71)</td><td align="char" valign="top" char="." charoff="50"><bold>0.04</bold></td></tr><tr><td align="left" valign="top" charoff="50">Needed additional enema (%)</td><td align="center" valign="top" charoff="50">8</td><td align="center" valign="top" charoff="50">5.3</td><td align="center" valign="top" charoff="50">3.4</td><td align="char" valign="top" char="." charoff="50">0.69</td></tr></tbody></table><table-wrap-foot><fn id="t2-fn1"><p>P/MC, sodium picosulfate plus magnesium citrate.</p></fn><fn id="t2-fn2"><p>Bold value highlight the <italic>P</italic>-value &lt;0.05.</p></fn></table-wrap-foot></table-wrap><table-wrap id="tbl3"><label>Table 3</label><caption><title>Patient symptoms after completing colon cleansing regimens</title></caption><table frame="hsides" rules="groups" border="1"><colgroup><col align="left"></col><col align="char" char="."></col><col align="char" char="."></col><col align="char" char="."></col><col align="char" char="."></col></colgroup><thead valign="bottom"><tr><th align="left" valign="top" charoff="50"><bold>Symptom</bold></th><th colspan="3" align="center" valign="top" char="." charoff="50"><bold>Group</bold><hr></hr></th><th align="center" valign="top" char="." charoff="50"><italic><bold>P</bold></italic>
<bold>value</bold></th></tr><tr><th align="left" valign="top" charoff="50"> </th><th align="center" valign="top" char="." charoff="50"><bold>P/MC alone (</bold><italic><bold>n</bold></italic><bold>=36)</bold></th><th align="center" valign="top" char="." charoff="50"><bold>P/MC plus sodium phosphate enema (</bold><italic><bold>n</bold></italic><bold>=29)</bold></th><th align="center" valign="top" char="." charoff="50"><bold>Sodium phosphate enema alone (</bold><italic><bold>n</bold></italic><bold>=38)</bold></th><th align="char" valign="top" char="." charoff="50"> </th></tr><tr><th align="left" valign="top" charoff="50"> </th><th align="center" valign="top" char="." charoff="50"><bold>%</bold></th><th align="center" valign="top" char="." charoff="50"><bold>%</bold></th><th align="center" valign="top" char="." charoff="50"><bold>%</bold></th><th align="char" valign="top" char="." charoff="50"> </th></tr></thead><tbody valign="top"><tr><td align="left" valign="top" charoff="50">Nausea</td><td align="char" valign="top" char="." charoff="50">33</td><td align="char" valign="top" char="." charoff="50">18</td><td align="char" valign="top" char="." charoff="50">3</td><td align="char" valign="top" char="." charoff="50">0.01</td></tr><tr><td align="left" valign="top" charoff="50">Vomiting</td><td align="char" valign="top" char="." charoff="50">2</td><td align="char" valign="top" char="." charoff="50">2</td><td align="char" valign="top" char="." charoff="50">0</td><td align="char" valign="top" char="." charoff="50">0.6</td></tr><tr><td align="left" valign="top" charoff="50">Abdominal pain</td><td align="char" valign="top" char="." charoff="50">38</td><td align="char" valign="top" char="." charoff="50">23</td><td align="char" valign="top" char="." charoff="50">10</td><td align="char" valign="top" char="." charoff="50">0.03</td></tr><tr><td align="left" valign="top" charoff="50">Dizziness</td><td align="char" valign="top" char="." charoff="50">16</td><td align="char" valign="top" char="." charoff="50">5</td><td align="char" valign="top" char="." charoff="50">0</td><td align="char" valign="top" char="." charoff="50">0.03</td></tr><tr><td align="left" valign="top" charoff="50">Bloating</td><td align="char" valign="top" char="." charoff="50">38</td><td align="char" valign="top" char="." charoff="50">15</td><td align="char" valign="top" char="." charoff="50">10</td><td align="char" valign="top" char="." charoff="50">0.01</td></tr><tr><td align="left" valign="top" charoff="50">Interrupted sleep</td><td align="char" valign="top" char="." charoff="50">16</td><td align="char" valign="top" char="." charoff="50">34</td><td align="char" valign="top" char="." charoff="50">0</td><td align="char" valign="top" char="." charoff="50">0.002</td></tr></tbody></table><table-wrap-foot><fn id="t3-fn1"><p>P/MC, sodium picosulfate plus magnesium citrate.</p></fn></table-wrap-foot></table-wrap></floats-group></article>